Dynamic Technology Lab Private Ltd Lowers Stock Holdings in Evolent Health, Inc. (NYSE:EVH)

Dynamic Technology Lab Private Ltd cut its holdings in Evolent Health, Inc. (NYSE:EVH - Free Report) by 89.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,577 shares of the technology company's stock after selling 101,971 shares during the quarter. Dynamic Technology Lab Private Ltd's holdings in Evolent Health were worth $327,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. William Blair Investment Management LLC raised its holdings in shares of Evolent Health by 35.2% during the second quarter. William Blair Investment Management LLC now owns 5,026,043 shares of the technology company's stock valued at $96,098,000 after purchasing an additional 1,308,376 shares during the last quarter. First Light Asset Management LLC grew its position in Evolent Health by 401.5% in the 2nd quarter. First Light Asset Management LLC now owns 1,445,305 shares of the technology company's stock worth $27,634,000 after purchasing an additional 1,157,124 shares during the period. Engaged Capital LLC raised its stake in Evolent Health by 26.1% during the 2nd quarter. Engaged Capital LLC now owns 4,111,458 shares of the technology company's stock valued at $78,611,000 after buying an additional 850,000 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Evolent Health by 24.8% during the 2nd quarter. Bank of New York Mellon Corp now owns 2,048,341 shares of the technology company's stock valued at $39,164,000 after buying an additional 406,837 shares during the period. Finally, Foundry Partners LLC purchased a new position in shares of Evolent Health in the 3rd quarter worth $10,042,000.

Evolent Health Trading Down 0.1 %

Evolent Health stock traded down $0.01 during midday trading on Friday, reaching $12.92. The stock had a trading volume of 1,102,713 shares, compared to its average volume of 3,654,132. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.58. The firm has a market cap of $1.51 billion, a price-to-earnings ratio of -14.20 and a beta of 1.58. Evolent Health, Inc. has a 52-week low of $11.17 and a 52-week high of $35.00. The company has a fifty day moving average of $21.47 and a 200 day moving average of $23.33.

Analyst Ratings Changes

EVH has been the subject of a number of research reports. Citigroup reduced their price objective on Evolent Health from $33.00 to $21.00 and set a "buy" rating for the company in a research report on Wednesday, November 13th. JMP Securities decreased their target price on Evolent Health from $34.00 to $31.00 and set a "market outperform" rating on the stock in a report on Friday, August 9th. Truist Financial reiterated a "buy" rating and set a $33.00 target price on shares of Evolent Health in a research report on Tuesday, August 27th. Royal Bank of Canada restated an "outperform" rating and issued a $20.00 price target on shares of Evolent Health in a research report on Tuesday, November 12th. Finally, Barclays lowered their price objective on Evolent Health from $39.00 to $19.00 and set an "overweight" rating on the stock in a research report on Monday, November 11th. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $25.90.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.